Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise?
Fool.com Headlines
Wild Reaches 900,000+ Verified Members Across 57 Countries, Challenging What Dating Apps Are Supposed to Be
PR Newswire
Antares Metals calls October 2026 meeting to ratify major share placement and options issue
TipRanks
Jazz Pharmaceuticals (JAZZ) Places An $820M Epilepsy Bet
Insider Monkey
Direxion Daily CSI 300 China A Share Bear 1X Shares (NYSEARCA:CHAD) to Issue Dividend of $0.08
The Cerbat Gem
ByteDance's second AI-agent phone drops forced automation for permission — yet app wall still up
DigiTimes: IT news from Asia
CoreWeave Stock (CRWV) Falls on $3B Convertible Debt Raise - Why Rosenblatt Remains Bullish
TipRanks
Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript
Fool.com Headlines
Indian Shares Set To Follow Global Peers Higher As Inflation Concerns Ease
Nasdaq News: Markets
Why Enova International Stock Was Plummeting This Week
Nasdaq News: Markets
Is Progressive Stock a Buy, Sell, or Hold About 10% Below Its 52-Week High?
Nasdaq News: Markets
Is Oklo (OKLO) Trading At A Premium After Its $1B Offering?
Simply Wall St
